Amphastar Pharmaceuticals Inc AMPH

NAS: AMPH | ISIN: US03209R1032 17/07/2025

21,70 USD (+2,02%)

(+2,02%) 17/07/2025

Grafiek Amphastar Pharmaceuticals Inc

Grafiek Amphastar Pharmaceuticals Inc

1 dag1d 2,02%
1 week1w -1,14%
1 maand1m -11,64%
3 maanden3m -7,66%
6 maanden6m -39,77%
1 jaar1j -45,22%
5 jaar5j 3,68%

Amphastar Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

14 juni 2024 · BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC · Persbericht

24 april 2023 · Lilly to Divest BAQSIMI to Amphastar · Persbericht

15 maart 2021 · Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020 · Persbericht

8 maart 2021 · Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021 · Persbericht

26 februari 2021 · Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference · Persbericht

Profiel Amphastar Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.amphastar.com

Hoofdzetel: Rancho Cucamonga, California Verenigde Staten

CEO: Jack Zhang

Werknemers: 312

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe